AndhraNews.net
Home » Features » Health » Body Mass Index

Body Mass Index


About Body Mass Index

A professor at the University of Nevada, Reno, has developed a new easy method for people to calculating their healthy weight, and that too without any need for charts or online calculators.

Body Mass Index in News

Curb Energy Consumption
(Family Features) Water heaters are energy intensive appliances. In fact, they are the second largest energy user in the home, and as they age, they become less efficient, requiring even more energy.

Boston Therapeutics' sugardown(R) in Clinical Trials Reduces Glucose, Fructose and Insulin
Boston Therapeutics, Inc. (OTCQB: BTHE) released final trial results from its proof of concept (POC) Sydney University study that showed consumption of sugardown® tablets prior to sugary beverages was found to significantly reduce the postprandial glucose, fructose and insulin responses to the sugary soft drink beverage. Every subject had a favorable response

Allurion Technologies' Elipse (TM) Gastric Balloon Receives European Marketing Approval
WELLESLEY, MA--(Marketwired - December 17, 2015) - Allurion Technologies announced today that its Elipse™ Gastric Balloon has received a CE mark allowing sale of the product in the European Union. This is the company's first regulatory approval. Elipse™ will initially be available in select leading weight loss centers in France, Italy and the United Kingdom

5 Tips for Surviving Black Friday Shopping Presented by Beauty Research
Recent surveys found that 1 out of every 3 Americans plans to shop on Black Friday, the Friday after Thanksgiving. To attract crowds, nearly all brick and mortar retailers will offer some type of sales event that day, giving shoppers the opportunity to purchase holiday gifts and items for themselves at discounted prices

VIVUS Reports Third Quarter 2015 Financial Results
MOUNTAIN VIEW, CA--(Marketwired - November 04, 2015) - VIVUS, Inc. (NASDAQ: VVUS) (the "Company"), a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet needs in obesity and sexual health, today provided a business update and reported its financial results for the third quarter ended September 30, 2015.

Chicago Weight Loss Practice Introduces Non-Surgical ORBERA Weight Loss System
A new weight loss program seeks to revolutionize the bariatric field, according to the surgeons at Suburban Surgical Care Specialists (SSCS). They explain that conventional weight loss methods emphasize either diet and exercise modifications or provide surgical intervention

VIVUS Announces Qsymia Presentations at Obesity Week 2015
MOUNTAIN VIEW, CA--(Marketwired - November 03, 2015) - VIVUS, Inc. (NASDAQ: VVUS) (the "Company"), a biopharmaceutical company commercializing Qsymia® (phentermine and topiramate extended-release) capsules CIV for the treatment of obesity, today announced the following presentations at Obesity Week 2015, Los Angeles Convention Center

ZELTIQ(R) Receives FDA Clearance to Treat Submental Fat With Coolsculpting(R) Procedure
ZELTIQ® Aesthetics, Inc. (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology, today announced that it received an expanded clearance from the U.S

VIVUS Reports Second Quarter 2015 Financial Results
MOUNTAIN VIEW, CA--(Marketwired - July 30, 2015) - VIVUS, Inc

New Haven Bariatric Surgeon Details Nutrition Requirements Following Gastric Bypass Surgery
According to the Centers for Disease Control and Prevention (CDC), approximately 78.6 million Americans are currently obese. The organization indicates that obesity is linked with many of the leading causes of preventable death, including heart disease, stroke, and certain cancers. Dr

Boston Therapeutics & University at Buffalo's Translational Pharmacology Research Core Initiates BTI-320 Clinical Trials Alliance in Buffalo, NY and NYC's Chinatown
Boston Therapeutics, Inc. (OTCQB: BTHE) signed a Letter of Intent with Dr. Gene D

Orafti(R)Synergy1 From BENEO Provides New Opportunities to Fight Obesity in Children
A new study conducted by the research team of Professor Raylene Reimer from the University of Calgary in Canada shows that the prebiotic chicory root fiber Orafti®Synergy1 from BENEO improves appetite regulation and decreases food intake in overweight and obese children, helping those children to eat less, naturally.(i) (ii)

VIVUS Reports First Quarter 2015 Financial Results
MOUNTAIN VIEW, CA--(Marketwired - May 05, 2015) - VIVUS, Inc

Results From Lantheus Medical Imaging's First Phase 3 Study of Novel PET Cardiac Imaging Agent Flurpiridaz F 18 Presented at ICNC12
N. BILLERICA, MA--(Marketwired - May 04, 2015) - Lantheus Medical Imaging, Inc

VIVUS Announces New Discount Program Through Sam's Club for Qsymia Patients
MOUNTAIN VIEW, CA--(Marketwired - April 28, 2015) - VIVUS, Inc. (NASDAQ: VVUS), a biopharmaceutical company commercializing Qsymia® (phentermine and topiramate extended-release) capsules CIV for the treatment of obesity, today announced that effective May 1, 2015, Qsymia will be the sole anti-obesity agent available on the Sam's Club Extra Value Drug List (EVDL)

Takeda Reports Five-Year Overall Survival Data for ADCETRIS® (Brentuximab Vedotin) Demonstrate Durable Remissions in Relapsed/Refractory Hodgkin Lymphoma
Business Wire IndiaTakeda Pharmaceutical Company Limited (TSE:4502) announced post-treatment follow up data from the pivotal phase 2 study of single-agent brentuximab vedotin for the treatment of relapsed or refractory Hodgkin lymphoma following autologous stem cell transplantation (ASCT)

Takeda to Present Data from Ixazomib’s Phase 3 Study in Relapsed/Refractory Multiple Myeloma at Upcoming American Society of Hematology Annual Meeting
Business Wire IndiaTakeda Pharmaceutical Company Limited (TSE: 4502) announced that it will present Phase 3 data from the TOURMALINE-MM1 ixazomib clinical trial at the 57th American Society of Hematology (ASH) Annual Meeting to be held in Orlando, Florida from December 5 to 8, 2015

Seattle Genetics and Takeda Achieve Target Enrollment in Phase 3 ECHELON-1 Clinical Trial Evaluating ADCETRIS® (Brentuximab Vedotin) in Previously Untreated Advanced Hodgkin Lymphoma (HL)
Business Wire IndiaSeattle Genetics, Inc. (Nasdaq: SGEN) and Takeda Pharmaceutical Company Limited (TSE:4502) today announced that the companies have achieved completion of target patient enrollment in the phase 3 ECHELON-1 clinical trial

Saffolalife Urges Couples to Walk Together to #ProtectHerHeart
Business Wire IndiaOn World Heart Day, Saffolalife organized a unique initiative where several Mumbai couples along with Shilpa Shetty Kundra & Raj Kundra participated in a morning walk together. This first-of-its-kind event was hosted by Saffolalife to create awareness of women’s heart health in India

Morinaga Milk Industry: Probiotic Supplementation Causes Fat Loss in Overweight Adults
Business Wire IndiaMorinaga Milk Industry Co., Ltd. (TOKYO:2264), the second largest dairy product company in Japan, confirmed that its new probiotic ingredient, Bifidobacterium breve B-3, caused a significant reduction of body fat and modified metabolic function in adults with obese tendencies in a randomized, double-blind, parallel-controlled trial.


TEMPE, AZ--(Marketwired - December 29, 2014) - New Top-10 listings from American Traffic Solutions (ATS), the nation's leading provider of road safety cameras, names the Honda Accord as the most frequent make and model of vehicle caught running red lights in 2014, and finds most red-light runners were driving vehicles painted gray.

VIVUS Announces Favorable Formulary Positioning for Qsymia
MOUNTAIN VIEW, CA--(Marketwired - December 15, 2014) - VIVUS, Inc. (NASDAQ: VVUS), a biopharmaceutical company commercializing Qsymia® (phentermine and topiramate extended-release) capsules CIV for the treatment of obesity, today announced that Qsymia is the sole anti-obesity agent listed on the CVS/Caremark Performance Drug List, or PDL

Medicaid and Medicare Have Updated Codes to Accept Telehealth Services
Beginning January 2015, the Centers for Medicaid and Medicare (CMS) will begin reimbursement for a number of telehealth services that the agency hasn't covered before

Preparing for the Telehealth and mHealth Surge
Healthcare as we know it is in the midst of a radical transformation with the emergence of telemedicine, or telehealth and its adoption into practices across the U.S

VIVUS Reports Third Quarter 2014 Financial Results
MOUNTAIN VIEW, CA--(Marketwired - November 05, 2014) - VIVUS, Inc. (NASDAQ: VVUS), a biopharmaceutical company commercializing Qsymia® (phentermine and topiramate extended-release) capsules CIV for the treatment of obesity, today reported its financial results for the third quarter ended September 30, 2014 and provided a business update.

VIVUS Announces Qsymia Presentations at Obesity Week 2014

Huntsville Plastic Surgeon Highlights Benefits of Combining Abdominoplasty and Liposuction
"I include liposuction on essentially every true abdominoplasty that I do," reveals Huntsville plastic surgeon David L. Durst, MD. Most people, he explains, have a little bit of fat that could be contoured with a liposuction technique called VASER (Vibration Amplification of Sound Energy at Resonance), especially in the lateral waist area

Study Shows CPAP Use for Sleep Apnea Does Not Negatively Impact Sexual Quality of Life
AUSTIN, TX--(Marketwired - October 21, 2014) - Patients who use a continuous positive airway pressure (CPAP) device to treat obstructive sleep apnea (OSA) often believe that it makes them less sexually attractive, according to researchers at Rosalind Franklin University

Newly Published Data Highlight the Effects of Weight Loss With Qsymia in Type 2 Diabetes
MOUNTAIN VIEW, CA--(Marketwired - October 06, 2014) - VIVUS, Inc. (NASDAQ: VVUS) today announced the publication of a paper examining study results that demonstrate the positive impact of weight loss with Qsymia® (phentermine and topiramate extended-release) capsules CIV (PHEN/TPM ER) plus lifestyle modification on glycemic control in subjects with type 2 diabetes.

Rolling Strong Partners With American Association of Owner Operators (AAOO) to Provide Wellness Benefits

Presence Chicago Institute of Advanced Bariatrics, a World Class Destination for Surgical Weight Loss to Reverse Chronic Health Conditions
At Presence Chicago Institute of Advanced Bariatrics, having bariatric surgery is not just about weight loss. It's also about curing some medical conditions as supported by a clinical body of evidence

VIVUS Announces Acquisition of Topiramate-Related Patents From Janssen Pharmaceuticals
MOUNTAIN VIEW, CA--(Marketwired - August 25, 2014) - VIVUS, Inc. (NASDAQ: VVUS) today announced the acquisition of a group of patents from Janssen Pharmaceuticals, Inc. covering uses of topiramate as monotherapy and in combination with other pharmaceutical agents to treat a variety of medical conditions.

Leading Provider of Wellness Programs Bravo Wellness, LLC Receives $22 Million Investment
Bravo Wellness, LLC, a provider of innovative outcomes-based wellness programs, today announced a $22 million Series A minority investment from ABS Capital Partners, a leading investor in later-stage growth companies. Bravo Wellness will use the proceeds to expand its sales and marketing efforts and to continue to innovate and expand its solutions

VIVUS Reports Second Quarter 2014 Financial Results
MOUNTAIN VIEW, CA--(Marketwired - August 07, 2014) - VIVUS, Inc. (NASDAQ: VVUS), a biopharmaceutical company commercializing Qsymia® (phentermine and topiramate extended-release) capsules CIV for the treatment of obesity, today reported its financial results for the second quarter ended June 30, 2014 and provided a business update.

VIVUS Files Lawsuit Against Actavis for Infringement of Qsymia Patents
MOUNTAIN VIEW, CA--(Marketwired - June 12, 2014) - VIVUS, Inc. (NASDAQ: VVUS) today announced that it has filed a lawsuit in the U.S. District Court for the District of New Jersey against Actavis Laboratories FL, Inc., Actavis, Inc., and Actavis PLC, collectively referred to as Actavis.

Bariatric Telemedicine Helps Keep the Weight Off
An overwhelming majority of Americans are currently dieting or exercising in an attempt to lose or maintain weight, yet a whopping 93 percent admit to struggling with their goals. For the more than one-third of Americans plagued by obesity, that effort is even more challenging

Seattle Genetics and Takeda Report Phase 3 AETHERA Clinical Trial Data from ADCETRIS® (Brentuximab Vedotin) in Post-Transplant Hodgkin Lymphoma Patients at Risk of Relapse at ASH Annual Meeting
Seattle Genetics, Inc

Seattle Genetics and Takeda Announce Four-Year Survival Data from ADCETRIS® (Brentuximab Vedotin) Pivotal Trial in Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma at ASH Annual Meeting
Seattle Genetics, Inc. (Nasdaq: SGEN) and Takeda Pharmaceutical Company Limited (TSE:4502) has announced four-year overall survival (OS) data from the ADCETRIS (brentuximab vedotin) pivotal Phase 2 clinical trial in relapsed or refractory systemic anaplastic large cell lymphoma (ALCL)

Takeda Announces Abstracts for ADCETRIS® (brentuximab vedotin) in Hodgkin Lymphoma, Systemic Anaplastic Large Cell Lymphoma and Ixazomib in Multiple Myeloma to be Presented at 56th American Society of Hematology Annual Meeting

Seattle Genetics and Takeda Announce Positive Data from Phase 3 AETHERA Clinical Trial of ADCETRIS® (Brentuximab Vedotin) for Consolidation in Post-Transplant Hodgkin Lymphoma
Seattle Genetics, Inc

Seattle Genetics and Takeda Highlight Long-term Follow-up Data from ADCETRIS® (Brentuximab Vedotin) Pivotal Clinical Trials in Relapsed or Refractory Hodgkin Lymphoma and Systemic Anaplastic Large Cell Lymphoma at ASH 2013
Seattle Genetics, Inc

Sunovion Pharmaceuticals Inc. Announces FDA Approval of Latuda® (lurasidone HCl) as Monotherapy and Adjunctive Therapy in Adult Patients with Bipolar Depression
Sunovion Pharmaceuticals Inc. today announced that the U.S

New Retrospective Study Reports Greater Effectiveness of KCI ABThera™ System Compared to Traditional Technique
Kinetic Concepts, Inc

FDA Approves Epaned, a Liquid Form of Enalapril for Children and Adults
In the news release, "FDA Approves Epaned, a Liquid Form of Enalapril for Children and Adults," issued earlier today by Silvergate Pharmaceuticals, Inc., the correct contact phone number for information about Epaned is 1-855-379-0382. Please update your records accordingly. Complete corrected text follows.

Is a Tummy Tuck Right for Me? Sacramento Plastic Surgeon Discusses Importance of Consultations
For patients considering tummy tuck surgery, what many may not realize is that the success of the procedure largely depends on how well a person may be suited for it

CellaVision signs Term Sheet with potential Chinese distribution partner
CellaVision has signed a Term Sheet with Mindray, with the intention to reach agreement regarding distribution of CellaVisions products, especially in China and other emerging markets. "It is part of CellaVision's strategy to expand geographically by working with strong distribution partners with local knowledge

SoloHealth & eHealth Announce Strategic Partnership to Promote Individual and Family Health Insurance Awareness & Options
SoloHealth®, a consumer-driven healthcare technology company, and eHealth, Inc. (NASDAQ: EHTH), parent company of eHealthInsurance, announced today at the Health2.0 conference in San Francisco a strategic partnership to help expand consumer awareness and enrollment in individual, family and Medicare health insurance plans

InnerVision Medical Technologies Develops Ultrasound Device to Image Morbidly Obese
InnerVision Medical Technologies, Inc., a developmental-stage company engaged in research and development of high-resolution ultrasound systems, today announced completion of its prototype ultrasound device and early evaluation results for imaging morbidly obese patients

Boston Therapeutics Reports Positive Phase II Results of PAZ320 Are Published in July/August Issue of Endocrine Practice
Boston Therapeutics, Inc

Chicago Bariatric Surgeon Employs Innovative Weight Loss Technique for a More Comfortable Recovery
Dr. Peter Rantis and the bariatric surgeons at Suburban Surgical Care Specialists/Kane Center in Chicago seek to help patients lose weight safely and effectively. While patients should expect some discomfort after weight loss surgery, Dr

MYOS to Study Synergistic Effects of Myostatin Inhibition on Testosterone-Mediated Muscle Growth; Brigham and Women's Hospital, a Teaching Affiliate of Harvard Medical School, to Conduct the Study

Plandai's Upcoming Weight Loss Study Primed to Outperform Competing Trials
Goldman Small Cap Research, a stock market research firm focused on the small cap and microcap sectors, notes in a just published article that with a product that likely has the highest nutrient absorption rate into the bloodstream (bioavailability) in the industry, Plandai Biotechnology, Inc

La Jolla Pharmaceutical Company Announces Higher Galectin-3 and Lower eGFR Inverse Correlation Independently Confirmed by JASN Publication
La Jolla Pharmaceutical Company (OTCQB: LJPC) ("La Jolla" and "Company"), a leader in the development of therapeutics targeting galectin proteins, announced today that a recent online publication of the Journal of the American Society of Nephrology ("JASN") on June 13, 2013, by Conall M

Las Vegas Plastic Surgeons Offer Patients Non-Invasive Alternative to Liposuction
Drs. W. Tracy Hankins and Samuel Sohn, Las Vegas plastic surgeons, are proud to use state-of-the-art plastic surgery techniques at their private practice, Hankins & Sohn Plastic Surgery

Boston Therapeutics Addressing Unmet Medical Needs by Harnessing Complex Carbohydrate Chemistry
In a newly published Expert Briefing which appears at BioMedReports, David Platt, Ph.D., CEO of Manchester, NH-based Boston Therapeutics (OTCQB: BTHE), writes that Carbohydrates have been shown to play a fundamental role in normal cell functions as well as in major disease pathologies including cancer, cardiovascular disease and inflammatory diseases.

Boston Therapeutics Strategically Positioned to Focus Its Pipeline on Commercializing Pharmaceutical Drugs to Treat Diabetes and Inflammatory Disease: To Accelerate Commercialization of PAZ320 & IPOXYN(TM)
Boston Therapeutics, Inc. (OTCQB: BTHE) ("Boston Therapeutics" or "the Company"), a pharmaceutical company focused on developing and commercializing complex carbohydrate-based drugs to treat diabetes and inflammatory diseases, today announced it will focus its pipeline to accelerate the commercialization of PAZ320 and IPOXYN™.

Boston Therapeutics Reports Positive Phase ll Clinical Trial Results of PAZ320 in Patients With Type 2 Diabetes
Boston Therapeutics, Inc

CoreSource Introduces Enhanced Member Health Portal, Powered by HealthFitness
CoreSource, a leading national provider of benefit administration and health management services for self-funded employee benefit plans, announced today that its plan members across the country have access to an enhanced version of its integrated online consumer health portal -- the HealthCenter, now powered by HealthFitness, an affiliate of CoreSource.

Higher Midlife Fitness Can Impact Brain Health in Later Life
It turns out that what's good for your heart is also good for your brain. This is the conclusion of a new study from The Cooper Institute in collaboration with UT Southwestern Medical Center and Cooper Clinic

Dr. Manjiri Puraniks Presentation on 'Obesity, Gender and Depression' at the International Conference, Melbourne, Australia
The Australian and New Zealand Obesity Society (ANZOS) have organized an International Conference on Obesity to bring together a diversity of researchers and practitioners who are focused on the prevention, treatment and management of obesity

Start Your Healthier Future Today
(Family Features) When it comes to losing weight and getting into shape, good intentions are never quite enough. And there's not a quick-fix solution, either. It takes a well-balanced approach and a commitment to making healthy, long-term changes.

How to Love Your Heart
(Family Features) It beats about 100,000 times a day, 35 million times a year. It pumps blood through the body three times every minute, taking that blood on the equivalent of a 12,000 mile trek every 24 hours. Even at rest, it works twice as hard as the leg muscles of a person running. The heart is a remarkable, vital muscle that warrants great care and maintenance

Novartis drug Signifor® gains FDA approval as the first medication to treat Cushing's disease, a serious endocrine disorder
Novartis International AG /Novartis drug Signifor® gains FDA approval as the first medication to treat Cushing's disease, a serious endocrine disorder . Processed and transmitted by Thomson Reuters ONE.The issuer is solely responsible for the content of this announcement.

Independent Health Teams With Liazon for Private Benefits Exchange
Independent Health has begun offering its innovative health care plans through Liazon's award-winning Bright Choices® Exchange to employers. Bright Choices helps employers control the escalating cost of health care benefits while giving employees greater benefits choices. The program will be available to customers in Western New York beginning immediately.

Phase III Data Show Greater Compliance Across Demographic Groups With Agile Therapeutics' Contraceptive Patch Compared to an Oral Contraceptive
Agile Therapeutics presented findings from a phase III pivotal trial of AG200-15, Agile's investigational once-weekly combination contraceptive patch containing ethinyl estradiol (EE) in combination with levonorgestrel (LNG). The data were presented during the North American Forum on Family Planning

New Study Shows Higher Midlife Fitness Is Key to Healthier Aging
A new study from The Cooper Institute in collaboration with UT Southwestern Medical Center shows that individuals who are fit at midlife have fewer chronic diseases in their Medicare years and spend less time with these diseases

Eisai Receives Antiobesity Agent Belviq(R) (lorcaserin HC1) NDA from Arena Pharmaceuticals
Eisai Co., Ltd. announced today that all rights pertaining to the New Drug Application (NDA) (rights as the marketing authorization holder) for the antiobesity agent BELVIQ(R) (lorcaserin HCl) have been transferred to its U.S. subsidiary Eisai Inc. from Arena Pharmaceuticals, Inc. With the NDA transfer, Eisai Inc. will become the U.S

Boston Therapeutics Completes Enrollment in Phase ll Clinical Trial to Evaluate PAZ320 in Patients With Type 2 Diabetes
Boston Therapeutics, Inc

2013 International CES To Feature Record Amount of Exhibit Space
The Consumer Electronics Association (CEA)® today announced that the 2013 International CES® will feature a record amount of exhibit space, with the show floor totaling more than 1.87 million net square feet. The previous record was 1.862 million net square feet at the 2012 CES

Digital Health and Fitness Technology Expands by Nearly 25 percent at 2013 International CES
The Consumer Electronics Association (CEA)® today announced the nearly 25 percent growth of digital health and fitness technology at the 2013 International CES®. More than 215 exhibitors will showcase the latest digital health and fitness technologies at the world’s largest annual innovation event

5 or more cups of coffee per day cuts IVF success chance by 50 pc
Women who drink five or more cups of coffee a day severely reduce their chance of success from IVF treatment, according to Danish researchers.

Successful dieters marked by appetite-regulating hormones ratio
Researchers have found that a pre-diet measurement of two hormones related to weight regulation can help predict which dieters will be more likely to maintain their weight loss and who will not.

US agency approves first obesity drug in 13 years
The US Food and Drug Administration (FDA) have approved a weight-loss pill for the first time in 13 years.

Exposure to secondhand smoke may trigger diabetes and obesity
Adults who are exposed to secondhand smoke have higher rates of obesity and Type 2 diabetes than do nonsmokers without environmental exposure to tobacco smoke.

'Active' video games offer no physical benefits to kids
Many parents may think that active video games such as Wii FIt Balanceare are an easy solution to getting their kids off the couch, but a new study has found no physical benefits for children from these activities.

Omega-3 supplements lower inflammation in overweight older people
Researchers have found that omega-3 fatty acid supplements can lower inflammation in healthy, but overweight, middle-aged and older adults, suggesting that regular use of these supplements could help protect against and treat certain illnesses.

Global weight gain more damaging than population growth
Increasing levels of fatness around the world could have the same impact on global resources as adding an extra billion people to the planet, say researchers.

Parents 'afraid to discuss weight issues with kids'
As many as two out of three parents don't talk to their children about their weight, fearing that it will lead to them getting an eating disorder.

Modified weight loss surgery provides Type 2 diabetes reversal
An endocrinologist from India has suggested that modified bariatric surgery such as sleeve gastrectomy should be considered at an earlier stage of Type 2 diabetes, rather than as a last resort.

How to make kids more active
Children are more active if their TV time is restricted or they are involved in school sports clubs, among other associations, according to a study.

Kids who hate their mums likely to become obese
The quality of the emotional relationship between a mother and her child could affect the potential for that kid to be obese during adolescence, a new study has suggested.

Partner's snoring keeping you up at night? Here's what you can do
Many people tend to lose their sleep because of their other half's consistent snoring but simple changes in the lifestyle can potentially help them get rid of this quandary, a new study has suggested.

Overweight pregnant women 'should not eat for two'
Overweight women who are pregnant should avoid 'eating for two' and should stick to healthy diet and exercise, a new study has revealed.

Obesity doubles death risk after esophageal cancer surgery
Researchers have found that obesity increases the risk of cancer recurrence and cancer-related death in patients with esophageal cancer who have been treated with surgery.

63pc women complain of knee pain
More than half of middle-aged and mature women suffer from knee pain, a new study has revealed.

Pregnancy weight gain raises the risk of having a fat baby
Excessive weight gain during pregnancy seems to increase birthweight and the offspring's risk of obesity later in life, a new study has suggested.

Adolescent football players at higher risk for stroke
Adolescent football players may be at a higher risk of suffering from stroke, a new study has found.

Physical fitness, not weight loss, key to longevity
Being physically fit is more important than losing weight, when it comes to reducing death risks, a new study has suggested.

New Year's Resolutions: eHealthInsurance Shows That Keeping Health-Related Goals May Save You Money
Today eHealthInsurance (NASDAQ: EHTH), the leading online source of health insurance for individuals, families and small businesses, described how keeping your New Year's resolutions and utilizing key health insurance benefits can help you save money.

A&D Medical Announces mHealth Partnership With Tactio Software
A&D Medical has joined Tactio Software, integrating A&D Medical devices with Tactio TargetWeight PRO application for iPod Touch, iPhone & iPad, together providing you a complete home health system

Comment on this story

Share